You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CPD

Sudden Vision Loss in Young Adults: What's Next?

  • Authors: Catherine Vignal-Clermont, MD
  • CPD Released: 7/2/2021
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 7/2/2022, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US ophthalmologists and neurologists.

The goal of this activity is to increase competence in detection and differential diagnosis of Leber hereditary optic neuropathy (LHON) and to improve awareness of new treatment approaches.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Leber hereditary optic neuropathy (LHON) clinical presentation
    • LHON pathogenesis
    • Current and emerging LHON therapies
  • Have greater competence related to
    • LHON detection
    • Differential diagnosis (classic LHON, optic neuritis, LHON-multiple sclerosis)


Disclosures

WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.


Faculty

  • Catherine Vignal-Clermont, MD

    Department of Emergencies and Neuro Ophthalmology
    Rothschild Foundation Hospital Paris
    Department of Ophthalmology
    Centre National Hospitalier National d’Ophthalmologie des Quinze-Vingts
    Paris, France

    Disclosures

    Disclosure: Catherine Vignal-Clermont, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Alexion; Gensight Biologics; Santhera Pharma
    Served as a speaker or a member of a speakers bureau for: Novartis

Editors

  • Gillian Griffith, BA (Mod), MA

    Medical Education Director, WebMD Global, LLC

    Disclosures

    Disclosure: Gillian Griffith, BA (Mod), MA, has disclosed no relevant financial relationships.

  • Frances McFarland, PhD, MA

    Medical Writer, WebMD Global, LLC

    Disclosures

    Disclosure: Frances McFarland, PhD, MA, has disclosed no relevant financial relationships.

Content Reviewer

  • Robert Morris, PharmD

    Associate Director, Accreditation and Compliance

    Disclosures

    Disclosure: Robert Morris, PharmD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: ViiV Healthcare
    Owns stock, stock options, or bonds from: GlaxoSmithKline

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Apellis; DeepMind Technologies Inc; Novartis; Roche
Received grants for educational activities: Allergan
Owns stock, stock options, or bonds: Big Picture Medical; BitFount


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 1.25 continuing professional development credits (CPD).

    Approved by The Royal College of Ophthalmologists for 1.0 CPD point.

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Sudden Vision Loss in Young Adults: What's Next?

Authors: Catherine Vignal-Clermont, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CPD Released: 7/2/2021

Valid for credit through: 7/2/2022, 11:59 PM EST

processing....

The following cases are modeled on the interactive grand rounds approach. The questions within the activity are designed to test your current knowledge. After each question, you will be able to see whether you answered correctly and read evidence-based information that supports the most appropriate answer choice. The questions are designed to challenge you; you will not be penalized for answering the questions incorrectly. At the end of the activity, there will be a short post-test assessment based on the material presented.

Clinical Case 1: Patient History

Anthony is a 25-year-old student who consumes a high amount of alcohol. He presents to his general practitioner (GP) with signs of severe, subacute central vision deterioration in both eyes. His GP refers him to an ophthalmologist. Anthony tells the ophthalmologist that he does not feel any pain, but that his sight is blurry and that colors seem faded. He also reports that he first noticed the problem in his left eye about 3 months ago but is now having problems with both eyes. The ophthalmologist questions Anthony further and learns that his maternal grandmother and two uncles also experienced vision problems at an early age. The initial examination confirms a bilateral loss of visual acuity, such that no plate of color vision is perceptible. Fundus examination reveals that the right disc looks hyperemic with peripapillary dilation of small vessels, and the temporal part of the left optic disc is pale; on both sides, the central retinal vessels look tortuous (Figure 1).

Figure 1. Ocular Fundus of the Patient

 

Vision loss began in the left eye and is now bilateral. The left optic disc shows pseudoedema and temporal pallor, while the right optic disc shows hyperemia, pseudoedema, and peripapillary telangiectasis. Both discs show retinal vessel tortuosity. (Photo courtesy of Catherine Vignal-Clermont, MD.)

The ophthalmologist then performs a visual field examination, which reveals bilateral central scotoma. On the optical coherence tomography (OCT), there is a thickening of the peripapillary retinal nerve fiber layer (pRNFL) on the right side and a thinning of the pRNFL on the left side; on both sides the macular ganglion cells (GC), thickness is reduced.

  • Print